Alemtuzumab, Total-Body Irradiation, and Fludarabine Followed By Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

This study is ongoing, but not recruiting participants.

Study NCT00040846 Information provided by National Cancer Institute (NCI)

First Received: July 8, 2002 Last Updated: March 28, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)